Journal of Substance Abuse Treatment
Volume 27, Issue 4 , Pages 301-306 , December 2004

Increased caseloads in methadone treatment programs: Implications for the delivery of services and retention in treatment

  • Duncan Stewart, Ph.D.

      Affiliations

    • Home Office, London, UK
    • Corresponding Author InformationCorresponding address. Research Development and Statistics, Home Office, Room 411, Horseferry House, Dean Ryle Street, London SW1P 2AW. Tel.: +020 7217 8635
    • ,
  • Michael Gossop, Ph.D.

      Affiliations

    • National Addiction Centre, Institute of Psychiatry, London, UK
    • ,
  • John Marsden, Ph.D.

      Affiliations

    • National Addiction Centre, Institute of Psychiatry, London, UK

Received 5 February 2004 ,Revised 29 July 2004 ,Accepted 12 August 2004.

References 

  1. Advisory Council on the Misuse of Drugs. AIDS and Drug Misuse Part 1. London: Department of Health, HMSO; 1988;
  2. Ball J, Ross A. The effectiveness of methadone maintenance treatment. New York: Springer; 1991;
  3. Belding MA, McLellan AT, Zanis DA, Incmikoski R. Characterizing ‘nonresponsive’ methadone patients. Journal of Substance Abuse Treatment. 1998;15:485–492
  4. Bell J, Caplehorn JRM, McNeil DR. The effect of intake procedures on performance in methadone maintenance. Addiction. 1994;89:463–471
  5. Best D, Noble A, Ridge G, Gossop M, Farrell M, Strang J. The relative impact of waiting time and treatment admission on drug and alcohol use. Addiction Biology. 2002;7:67–74
  6. D’Aunno T, Vaughn TE. Variations in methadone treatment practices: results from a national study. Journal of the American Medical Association. 1992;267:253–258
  7. D’Aunno T, Vaughn TE. An organisational analysis of service patterns in outpatient drug abuse treatment units. Journal of Substance Abuse. 1995;7:27–42
  8. D’Aunno T, Folz-Murphy N, Lin X. Changes in methadone treatment practices: results from a panel study, 1988–1995. American Journal of Drug and Alcohol Abuse. 1999;25:681–699
  9. Department of Health. The Task Force to Review Services for Drug Misusers: Report of an independent review of drug treatment services in England. London: Department of Health; 1996;
  10. Department of Health. Statistics from the regional drug misuse databases for six months ending September 2000. London: Department of Health; 2001;
  11. Desmond D, Maddux J. Compulsory supervision and methadone maintenance. Journal of Substance Abuse Treatment. 1996;13:79–83
  12. Etheridge RM, Hubbard RL. Conceptualizing and assessing treatment structure and process in community-based drug dependency treatment programs. Substance Use and Misuse. 2000;35:1757–1795
  13. Etheridge RM, Craddock SG, Dunteman GH, Hubbard RL. Treatment services in two national studies of community-based drug abuse treatment programs. Journal of Substance Abuse. 1995;7:9–26
  14. Etheridge RM, Hubbard RL, Anderson J, Craddock SG, Flynn PM. Treatment structure and program services in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors. 1997;11:244–260
  15. Farrell M, Neeleman J, Gossop M, Griffiths P, Buning E, Finch E, et al. Methadone provision in the European Union. International Journal of Drug Policy. 1995;6:168–172
  16. Festinger DS, Lamb RJ, Kountz MR, Kirby KC, Marlowe D. Pretreatment dropout as a function of treatment delay and client variables. Addictive Behaviors. 1995;20:111–115
  17. In:  Gerstein D,  Harwood H editor. Treating drug problems: Volume 1. A study of the evolution, effectiveness, and financing of public and private drug treatment systems. Washington D.C.: National Academy Press; 1990;
  18. Gossop M, Grant M. A study of the content and structure of heroin treatment programs using methadone in six countries. British Journal of Addiction. 1991;86:1151–1160
  19. Gossop M, Marsden J, Stewart D, Kidd T. The National Treatment Outcome Research Study (NTORS): 4–5 year follow-up results. Addiction. 2003;98:291–303
  20. Gossop M, Stewart D, Marsden J. Treatment process components and heroin use outcomes among methadone patients. Drug and Alcohol Dependence. 2003;71:93–102
  21. Grella CE, Wugalter SE, Anglin MD. Predictors of treatment retention in enhanced and standard methadone maintenance treatment for HIV risk reduction. Journal of Drug Issues. 1997;27:203–224
  22. Hough M. Drug user treatment within a criminal justice context. Substance Use and Misuse. 2002;37:985–996
  23. Hser Y-I, Polinsky ML, Maglione M, Anglin MD. Matching clients’ needs with drug treatment services. Journal of Substance Abuse Treatment. 1999;16:299–305
  24. Hubbard RL, Marsden ME, Rachal JV, Harwood HJ, Cavanaugh ER, Ginzburg HM. Drug Abuse Treatment: A National Study of Effectiveness. London: Chapel Hill; 1989;
  25. Hubbard RL, Craddock SG, Flynn PM, Anderson J, Etheridge RM. Overview of 1 year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors. 1997;11:261–278
  26. Joe GW, Simpson DD, Hubbard RL. Treatment predictors of tenure in methadone maintenance. Journal of Substance Abuse. 1991;3:73–84
  27. Joe GW, Simpson DD, Sells SB. Treatment process and relapse to opioid use during methadone maintenance. American Journal of Drug and Alcohol Abuse. 1994;20:173–197
  28. MacGregor S, Smith LE, Flory P. The Drugs Treatment System in England. London: Middlesex University, School of Sociology and Social Policy; 1994;
  29. Magura S, Rosenblum A. Leaving methadone treatment: lessons learned, lessons forgotten, and lessons ignored. The Mount Sinai Journal of Medicine. 2001;68:62–74
  30. Magura S, Nwakeze P, Demsky S. Pre- and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction. 1998;93:51–60
  31. Marsch LA. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction. 1998;93:515–532
  32. McLellan AT, Arndt IO, Metzger DS, Woody GE, O’Brien C. The effects of psychosocial services in substance abuse treatment. Journal of American Medical Association. 1993;269:1953–1959
  33. McLellan AT, Alterman AI, Metzger DS, Grissom GR, Woody GE, Luborsky L, et al. Similarity of predictors across opiate, cocaine, and alcohol treatments: role of treatment services. Journal of Consulting and Clinical Psychology. 1994;62:1141–1158
  34. Saxon AJ, Wells EA, Fleming C, Jackson TR, Calsyn DA. Pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome. Addiction. 1996;91:1197–1209
  35. Simpson DD. Effectiveness of drug abuse treatment: a review of research from field settings. In:  Egertson JA,  Fox DM,  Leshner AI editor. Treating drug abusers effectively. Oxford: Blackwell; 1997;p. 41–74
  36. Simpson DD, Joe GW, Rowan-Szal GA. Drug abuse treatment retention and process effects on follow-up outcomes. Drug and Alcohol Dependence. 1997;47:227–235
  37. Stewart D, Gossop M, Marsden J, Strang J. Variation between and within drug treatment modalities: data from the National Treatment Outcome Research Study (UK). European Addiction Research. 2000;6:106–114
  38. Strain EC, Bigelow GE, Liebson IA, Stitzer ML. Moderate- vs high-dose methadone in the treatment of opioid dependence. Journal of the American Medical Association. 1999;281:1000–1005
  39. Zanis DA, McLellan AT, Alterman AI, Cnaan RA. Efficacy of enhanced outreach counseling to re-enroll high-risk drug users 1 year after discharge from treatment. American Journal of Psychiatry. 1996;153:1095–1096

PII: S0740-5472(04)00096-0

doi: 10.1016/j.jsat.2004.08.006

Journal of Substance Abuse Treatment
Volume 27, Issue 4 , Pages 301-306 , December 2004

Article Tools